A panel of CDC advisers will meet Friday to discuss what to do about Johnson & Johnson’s COVID-19 vaccine.
The vaccine was ‘paused’ earlier this month after reports of rare but potentially serious blood clot issues.
The committee met last week but decided more information was needed.
Friday’s meeting could end with the committee recommending the vaccine continue, or halted completely.
For more information, click here.